SCHEMBL7301655

SCHEMBL7301655

CC(C)C(Nc1nc2ccccc2[nH]1)C(N)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.58
LMNA P02545 2/20 0.55
RAB9A P51151 9/20 0.50
NPC1 O15118 8/20 0.50
SMN1; SMN2 Q16637 7/20 0.50
HTT P42858 2/20 0.50
FFAR2 O15552 1/20 0.50
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
MITF O75030 1/20 0.49
POLB P06746 1/20 0.49
PKM P14618 2/20 0.49
MAOB P27338 1/20 0.49
ADORA2A P29274 1/20 0.49
KLF5 Q13887 2/20 0.48
OPRK1 P41145 1/20 0.48
ALDH1A1 P00352 2/20 0.46
MAPK1 P28482 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8779893 0.78 LMNA (0.59) CYP3A4LMNARAB9ANPC1SMN1; SMN2
SCHEMBL8779899 0.78 LMNA (0.59) CYP3A4LMNARAB9ANPC1SMN1; SMN2
SCHEMBL8779898 0.78 LMNA (0.59) CYP3A4LMNARAB9ANPC1SMN1; SMN2
SCHEMBL5133337 0.77 LMNA (0.53) CYP3A4LMNARAB9ANPC1SMN1; SMN2
SCHEMBL11989038 0.77 ALDH1A1 (0.61) CYP3A4LMNARAB9ANPC1SMN1; SMN2
SCHEMBL7340481 0.76 MPO (0.51) CYP3A4LMNARAB9ANPC1SMN1; SMN2
SCHEMBL7301661 0.75 LMNA (0.62) CYP3A4LMNARAB9ANPC1SMN1; SMN2
SCHEMBL29776932 0.74 CYP3A4 (1.00) CYP3A4LMNARAB9ANPC1SMN1; SMN2
SCHEMBL707208 0.74 CYP3A4 (1.00) CYP3A4LMNARAB9ANPC1SMN1; SMN2
SCHEMBL18634235 0.74 LMNA (0.53) CYP3A4LMNARAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0337714-A2 HIV protease inhibitors useful for the treatment of aids MERCK & CO. INC. (US) 1989-10-18 EP claimed
EP-0337714-A2 HIV protease inhibitors useful for the treatment of aids MERCK & CO. INC. (US) 1989-10-18 EP disclosed